Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rapid decay of tree-community composition in Amazonian forest fragments.
Laurance WF, Nascimento HE, Laurance SG, Andrade A, Ribeiro JE, Giraldo JP, Lovejoy TE, Condit R, Chave J, Harms KE, D'Angelo S. Laurance WF, et al. Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19010-4. doi: 10.1073/pnas.0609048103. Epub 2006 Dec 5. Proc Natl Acad Sci U S A. 2006. PMID: 17148598 Free PMC article.
Pervasive alteration of tree communities in undisturbed Amazonian forests.
Laurance WF, Oliveira AA, Laurance SG, Condit R, Nascimento HE, Sanchez-Thorin AC, Lovejoy TE, Andrade A, D'Angelo S, Ribeiro JE, Dick CW. Laurance WF, et al. Nature. 2004 Mar 11;428(6979):171-5. doi: 10.1038/nature02383. Nature. 2004. PMID: 15014498 Free article.
Environment. The future of the Brazilian Amazon.
Laurance WF, Cochrane MA, Bergen S, Fearnside PM, Delamônica P, Barber C, D'Angelo S, Fernandes T. Laurance WF, et al. Science. 2001 Jan 19;291(5503):438-9. doi: 10.1126/science.291.5503.438. Science. 2001. PMID: 11228139 No abstract available.
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults.
Winter EM, Dekkers OM, Andreasen CM, D'Angelo S, Appelman-Dijkstra NM, Appenzeller S, Assmann G, Bubbear JS, Bulaicon OO, Chapurlat R, Choida V, Clunie GPR, Daoussis D, Diekhoff T, Flendrie M, Fogel O, Ghossan R, Girschick H, van Haalen F, Hamdy NAT, Hauser B, Hedrich CM, Helliwell PS, Hermann KG, Insalaco A, Jurik AG, Kishimoto M, Lems W, Miettunen P, Muche B, Navas Cañete A, Palmou-Fontana N, Smit F, Teh J, Verroken C, de Vlam K, Wendling D, Zhou W, Zmierczak HG, Leerling AT. Winter EM, et al. Among authors: d angelo s. Ann Rheum Dis. 2024 Nov 28:ard-2024-226446. doi: 10.1136/ard-2024-226446. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39608805 Free article.
Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies.
Gormally MV, Chen MF, Noronha AM, Panageas K, Reynolds M, Kohlasch K, Novak B, Kee-Velez T, Clarke N, Eubank M, Chu C, Wilhelm C, Blouin A, Kyi C, Friedman C, Rudin CM, Kris MG, Shah R, Aggen D, D'Angelo S, Shoushtari AN, Berger MF, Bandlamudi C, Klebanoff CA, Drilon A, Schoenfeld AJ, Donoghue MTA. Gormally MV, et al. Among authors: d angelo s. JAMA Oncol. 2024 Nov 27:e245364. doi: 10.1001/jamaoncol.2024.5364. Online ahead of print. JAMA Oncol. 2024. PMID: 39602136
AIntibody: an experimentally validated in silico antibody discovery design challenge.
Erasmus MF, Spector L, Ferrara F, DiNiro R, Pohl TJ, Perea-Schmittle K, Wang W, Tessier PM, Richardson C, Turner L, Kumar S, Bedinger D, Sormanni P, Fernández-Quintero ML, Ward AB, Loeffler JR, Swanson OM, Deane CM, Raybould MIJ, Evers A, Sellmann C, Bachas S, Ruffolo J, Nastri HG, Ramesh K, Sørensen J, Croasdale-Wood R, Hijano O, Leal-Lopes C, Shahsavarian M, Qiu Y, Marcatili P, Vernet E, Akbar R, Friedensohn S, Wagner R, Kurella VB, Malhotra S, Kumar S, Kidger P, Almagro JC, Furfine E, Stanton M, Graff CP, Villalba SD, Tomszak F, Teixeira AAR, Hopkins E, Dovner M, D'Angelo S, Bradbury ARM. Erasmus MF, et al. Among authors: d angelo s. Nat Biotechnol. 2024 Nov;42(11):1637-1642. doi: 10.1038/s41587-024-02469-9. Nat Biotechnol. 2024. PMID: 39496931 No abstract available.
Expect the unexpected: fulminant myocardial cytotoxic Injury from Trabectedin.
Tsay AJ, Satish M, Corley E, Ezema A, DeJesus N, Wisely S, McAleer E, Zhang C, Yuan S, Homan E, Liu JE, Weinsaft JW, D'Angelo S, Feldman SA, Chan AT. Tsay AJ, et al. Among authors: d angelo s. Cardiooncology. 2024 Oct 15;10(1):70. doi: 10.1186/s40959-024-00257-7. Cardiooncology. 2024. PMID: 39407287 Free PMC article.
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.
Movva S, Seier K, Avutu V, Banks LB, Chan J, Chi P, Dickson MA, Gounder MM, Kelly CM, Keohan ML, Maki R, Rosenbaum E, Salcito T, Rodriguez K, Dempsey R, Meyers PA, Cohen SM, Hensley ML, Konner JA, Schram AM, Lefkowitz RA, Erinjeri JP, Qin LX, Tap WD, D'Angelo SP. Movva S, et al. Among authors: d angelo sp. Clin Cancer Res. 2024 Dec 16;30(24):5612-5619. doi: 10.1158/1078-0432.CCR-24-2519. Clin Cancer Res. 2024. PMID: 39405335
686 results